Nurix Therapeutics Inc
NASDAQ:NRIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nurix Therapeutics Inc
NASDAQ:NRIX
|
US |
|
L
|
Larq SA
WSE:LRQ
|
PL |
|
Gold by Gold SA
PAR:ALGLD
|
FR |
|
M
|
Metech International Ltd
SGX:V3M
|
SG |
|
M
|
Mitsib Leasing PCL
SET:MITSIB
|
TH |
Wall Street
Price Targets
NRIX Price Targets Summary
Nurix Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
NRIX
is 30.6 USD
with a low forecast of 22.22 USD and a high forecast of 43.05 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NRIX's stock price target?
Price Target
30.6
USD
According to Wall Street analysts, the average 1-year price target for
NRIX
is 30.6 USD
with a low forecast of 22.22 USD and a high forecast of 43.05 USD.
What is Nurix Therapeutics Inc's Revenue forecast?
Projected CAGR
19%
For the last 6 years the
compound annual growth rate for
Nurix Therapeutics Inc's revenue is
18%.
The projected
CAGR
for the next 3 years is
19%.
